Clinical trial
PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin
NCT04856683 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 10, 2020
- Completion date
- August 9, 2024
- Enrollment
- 1,100 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.